Dominik Höchli
Direttore/Membro del Consiglio presso MOLECULAR PARTNERS AG
Posizioni attive di Dominik Höchli
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| MOLECULAR PARTNERS AG | Direttore/Membro del Consiglio | 21/04/2021 | - |
| Independent Dir/Board Member | 21/04/2021 | - | |
Catapult Therapeutics BV
 Catapult Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Catapult Therapeutics BV operates as a biopharmaceutical company which develops cancer treatments. It is developing CAP-100, a humanized anti-CCR7 antibody. The company was founded in 2015 and is headquartered in Lelystad, the Netherlands. | Amministratore Delegato | 01/01/2021 | - |
Storia della carriera di Dominik Höchli
Precedenti posizioni note di Dominik Höchli
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| AbbVie AG | Corporate Officer/Principal | - | - |
Formazione di Dominik Höchli
| University of Bern | Doctorate Degree |
Statistiche
Distribuzione geografica
| Svizzera | 4 |
| Paesi Bassi | 2 |
Posizioni
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
| Doctorate Degree | 1 |
Settori
| Consumer Services | 2 |
| Health Technology | 2 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| MOLECULAR PARTNERS AG | Health Technology |
| Aziende private | 2 |
|---|---|
| AbbVie AG | |
Catapult Therapeutics BV
Catapult Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Catapult Therapeutics BV operates as a biopharmaceutical company which develops cancer treatments. It is developing CAP-100, a humanized anti-CCR7 antibody. The company was founded in 2015 and is headquartered in Lelystad, the Netherlands. | Commercial Services |
- Borsa valori
- Insiders
- Dominik Höchli
- Esperienza
